iRadimed (IRMD)
(Delayed Data from NSDQ)
$45.00 USD
+0.11 (0.25%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $45.01 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$45.00 USD
+0.11 (0.25%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $45.01 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
IRadimed (IRMD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
iRadimed (IRMD) delivered earnings and revenue surprises of 16.67% and 1.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (ACHC) Opens Facility to Serve California
by Zacks Equity Research
Acadia Healthcare (ACHC) conducts a ribbon-cutting ceremony for its Indio-based acute care facility, which aims to cater to the dire need for high-quality behavioral healthcare services in the region.
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
by Zacks Equity Research
UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.
Centene's (CNC) Ambetter Enhances Offerings With Broward Health
by Zacks Equity Research
Centene's (CNC) Health Insurance Marketplace brand Ambetter strengthens its provider network with Broward Health.
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
by Zacks Equity Research
Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.
5 Small Hidden Gems for the Rest of 2023
by Nalak Das
We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX.
Humana's (HUM) 2024 MA Plans Promise a Wider Set of Benefits
by Zacks Equity Research
Humana (HUM) aims to expand the reach of its Medicare plans across newer U.S. counties in 2024 through integrating multiple lucrative benefits within them.
Zacks.com featured highlights include NVIDIA, iRadimed, Perdoceo Education and Axcelis Technologies
by Zacks Equity Research
NVIDIA, iRadimed, Perdoceo Education and Axcelis Technologies are part of the Zacks screen of the Week article.
4 Top Profitable Stocks to Invest in Using Net Income Ratio
by Tirthankar Chakraborty
NVIDIA (NVDA), iRadimed (IRMD), Perdoceo Education (PRDO) and Axcelis Technologies (ACLS) have been selected as the top picks with a high net income ratio.
Encompass Health (EHC) Up 41% in a Year: More Room for Growth?
by Zacks Equity Research
Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.
Zacks.com featured highlights iRadimed, PulteGroup and NVIDIA
by Zacks Equity Research
iRadimed, PulteGroup and NVIDIA have been highlighted in this Screen of The Week article.
Community Health (CYH), Mindoula to Offer Mental Health Care
by Zacks Equity Research
Community Health (CYH) collaborates with Mindoula to enhance the availability of behavioral health resources to its affiliated provider network, who can now treat patients better.
Top 3 Profitable Stocks to Buy Now Using Net Income Ratio
by Tirthankar Chakraborty
iRadimed (IRMD), PulteGroup (PHM) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
Select Medical (SEM) Up 18% Year to Date: More Room to Run?
by Zacks Equity Research
Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with strong cash-generating abilities.
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
by Zacks Equity Research
iRadimed (IRMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Acadia Healthcare (ACHC) Up 11% in 3 Months: More Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) is well-poised for growth on an expansive healthcare portfolio, which in turn, boosts its patient volumes.
Zacks.com featured highlights Perdoceo Education, Boot Barn and iRadimed
by Zacks Equity Research
Perdoceo Education, Boot Barn and iRadimed have been highlighted in this Screen of The Week article.
3 Top Profitable Stocks to Invest in Using Net Income Ratio
by Tirthankar Chakraborty
Perdoceo Education (PRDO), Boot Barn (BOOT) and iRadimed (IRMD) have been selected as the top picks with a high net income ratio.
Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?
by Ethan Feller
Want to start the week ahead of the pack? Check out Momentum Mondays!
Time to Buy These Medical Stocks as Earnings Approach
by Shaun Pruitt
Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.
HCA Healthcare (HCA) Rises 24% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare (HCA) is well-poised for growth on the back of improved patient occupancy levels, effective telehealth services suite and solid cash-generating abilities.
iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
IRadimed (IRMD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
iRadimed (IRMD) delivered earnings and revenue surprises of 16.13% and 2.74%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
2 Medical Stocks to Consider Buying in June
by Shaun Pruitt
With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.
iRadimed (IRMD) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.